Pfizer Inc. (NYSE: PFE) → Stocks, dividends, news, and other

Pfizer Inc.

Free disabling of ads
Dividends News

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

  • PFE Symbol
  • NYSE Exchange
  • 92,400 Employees
36 rated
  • $38.18, +$0.75 (+2.00%) Previous Close
  • 28,961,367 Previous Volume
  • $27.88 / $40.97 52 week low / high
  • -6.81% Percent off 52 week high
  • 2020-10-23 Updated
  • 3.93% Dividend yield (trailing)
  • 3.98% Dividend yield (forward)
  • 5,553,929,297 Public float
  • 5,556,880,000 Outstanding shares
  • 14.98 P/E
  • 207.99 B Market Cap
Free disabling of ads

Financial statements

The information is not 100% up-to-date. There may be errors or something missing. Often something is missing, there are almost no errors, but I can't rule them out. Now I'm looking for a supplier of high-quality information, but so far what I find is expensive (about $ 2000 a year).
2015 2016 2017 2018 2019
Total Revenue 49B 53B 53B 54B 52B
Cost Of Revenue 13B 16B 16B 16B 10B
Gross Profit 36B 37B 37B 38B 42B
Research and Development 7.7B 7.8B 7.6B 8B 8.7B
Selling General and Admin 15B 15B 15B 14B 14B
Operating Expense 36B 39B 38B 38B 33B
Operating Income 13B 14B 14B 15B 14B
Other Income Expense Net -4.3B -5.9B -2.1B -3.4B 3.8B
EBIT 13B 14B 14B 15B 14B
Interest Income 1.2B 1.2B 1.3B 1.3B 1.6B
Pretax Income 9B 8.4B 12B 12B 18B
Income Tax 2B 1.1B -9B 710M 1.4B
Minority Interest 26M 31M 47M 36M 29M
Net Income 7B 7.2B 21B 11B 16B
Net Income Basic 7B 7.2B 21B 11B 16B
2015 2016 2017 2018 2019
Current cash 3.6B 2.6B 1.3B 1.2B 1.3B
Short term investments 20B 15B 19B 18B 8.5B
Receivables 8.2B 8.2B 8.2B 8B 8.7B
Inventory 7.5B 6.8B 7.6B 7.5B 8.3B
Other current assets 4.8B 6.1B 5.4B 16B 6B
Current assets 44B 39B 41B 50B 33B
Long term investments 16B 7.1B 7B 2.8B 20B
Property plant equipment 14B 13B 14B 13B 15B
Goodwill 48B 54B 56B 53B 59B
Intangible assets 40B 53B 49B 35B 35B
Other assets 3.5B 3.3B 3.2B 2.8B 3.1B
Total assets 170B 170B 170B 160B 170B
Accounts payable 3.6B 4.5B 4.7B 4.7B 4.2B
Current long term debt 3.7B 4.2B 3.5B 4.8B 1.5B
Other current liabilities 15B 15B 15B 17B 16B
Total current liabilities 29B 31B 30B 32B 37B
Long term debt 29B 31B 34B 33B 37B
Other liabilities 5.3B 6.3B 6.1B 5.9B 5.3B
Minority Interest 26M 31M 47M 36M 29M
Total Liabilities 100B 110B 100B 96B 100B
Common stock 6.2B 6.1B 6B 5.7B 5.5B
Retained earning 72B 72B 85B 90B 98B
Treasury stock 3.8M 3.4M 3M 4.2M 3.7M
Capital surplus 81B 83B 84B 86B 87B
Shareholder equity 65B 60B 71B 63B 63B
Net tangible assets -120B -150B -150B -140B -150B
2015 2016 2017 2018 2019
Net Income 7B 7.2B 21B 11B 16B
Depreciation 5.2B 5.8B 6.3B 6.4B 6B
Changes in receivables -49M 4M 200M -700M
Changes in inventories -200M 370M -360M -720M -1.1B
Cash change 300M -1B -1.3B -210M 130M
Cash flow 15B 16B 16B 16B 13B
Capital expenditures -1.5B -2B -2.2B -2.2B -2.6B
Investments 15B 13B -2.2B 6.4B 9.3B
Investing activity other -1M
Total investing cash flows -3B -7.8B -4.7B 4.5B -3.9B
Dividends paid -6.9B -7.3B -7.7B -8B -8B
Net borrowings 1.3B 2.6B -1B -940M 8.8B
Other financing cash flows 300M -200M -230M -590M -740M
Cash flow financing -10B -8.9B -13B -20B -8.5B
Exchange rate effect -1B -220M 53M -120M -32M
Free disabling of ads
Free disabling of ads